{
  "thesis_id": "P3",
  "role": "Vaticinus World Graph Specialist",
  "findings": [
    "Clause P3 has a clause_p of 44 and vision_p of 76, indicating moderate initial conviction at board time but demanding verification.",
    "No primary source packs, substitute paths, scenario branches, or entity resolution nodes are filled for P3; all six tasks in each category remain open, placing the graph at a pre-evidence stage.",
    "The kill condition requires model-only AI discovery companies to repeatedly produce commercially validated materials or therapies without materially expanding wet-lab or physical-test throughput by 2029; satisfaction would directly falsify the bottleneck shift (i.e., model quality remains the true limit).",
    "The metric spans DOE/national-lab testbed awards, pharma/materials partnerships that purchase autonomous lab capacity, assay throughput per researcher, and publications where the bottleneck is experiment generation rather than model inference.",
    "The watch signal (a major pharma, chemicals, or materials company publicly citing lab throughput as the AI discovery bottleneck) remains unobserved; no such public claim has been verified.",
    "Coverage score for the graph is 85%, but this number is dominated by the larger domain structure; P3-specific verification is effectively zero.",
    "The structural thesis is that when AI-driven discovery becomes abundant, the scarce resource shifts to robotic experimental throughput with standardized metadata, reliable assay replication, and closed-loop execution—this is a falsifiable claim about the marginal constraint."
  ],
  "proposed_nodes": [
    {
      "id": "n-source-p3-primary-source-pack",
      "kind": "source_pack",
      "label": "Primary source pack for P3",
      "description": "Aggregate primary sources (e.g., DOE ARPA-E, ATAP, or lab testbed awards, company press releases, peer-reviewed papers) that either support or contradict the claim that experimental throughput is the binding constraint."
    },
    {
      "id": "n-scenario-p3-branches",
      "kind": "scenario_branch",
      "label": "Scenario branches for P3",
      "description": "Base (bottleneck confirmed, autonomous labs grow), upside (throughput scales rapidly, leading to multiple commercial breakthroughs), downside (model-only firms succeed without lab expansion, killing the thesis)."
    },
    {
      "id": "n-substitute-p3-path",
      "kind": "substitute_path",
      "label": "Substitute paths that bypass experimental throughput",
      "description": "Advances in in-silico prediction (e.g., quantum chemistry, deep learning force fields) or virtual screening that reduce the need for physical experiments could shift the bottleneck back to model quality, weakening the thesis."
    },
    {
      "id": "n-entity-p3-canonical",
      "kind": "entity_resolution",
      "label": "Canonical entities for P3",
      "description": "Resolve key entities: DOE testbed programs (e.g., the Autonomous Discovery Formulation Lab, CRADA partners), national labs (Argonne, ORNL, LBNL), pharma partners (insitro, Recursion, Schrödinger), autonomous lab platforms (Emerald Cloud Lab, Strateos, Arctoris), materials companies (Citrine, Toyota Research Institute), and metrics sources (Nature papers, DOE reports)."
    }
  ],
  "proposed_edges": [
    {
      "id": "e-p3-source-pack-supports-constraint",
      "src": "n-source-p3-primary-source-pack",
      "dst": "n-constraint-robotic-experimental-throughput-with-standardized-metadata-reliable-a-6881a685",
      "rel": "supports",
      "rationale": "If the source pack contains direct evidence of experimental throughput being the binding constraint, this edge will be instantiated with confidence."
    },
    {
      "id": "e-p3-metric-scored-by-source",
      "src": "n-metric-track-doe-and-national-lab-testbed-awards-pharma-materials-partnerships-t-629546ac",
      "dst": "n-source-p3-primary-source-pack",
      "rel": "verified_by",
      "rationale": "The metric's scoring reliability depends on primary source verification; once sources are attached, the metric node can be scored."
    },
    {
      "id": "e-p3-kill-falsified-by-downside-scenario",
      "src": "n-kill-condition-kill-if-by-2029-model-only-ai-discovery-companies-repeatedly-produce-commercially-validated... (node_id for kill condition missing from provided samples, can be resolved)",
      "dst": "n-scenario-p3-branches",
      "rel": "falsified_by",
      "rationale": "The downside scenario branch would model conditions where model-only companies succeed, directly triggering the kill condition."
    }
  ],
  "verification_tasks": [
    {
      "id": "vt-p3-source-pack",
      "kind": "source_pack",
      "priority": "critical",
      "owner_agent": "A01",
      "question": "Attach primary/official source URLs and publication dates to every load-bearing node for P3.",
      "required_evidence": "source_url, source_date, quote_or_field, trust_rational
